Background: Functional dyspepsia is a heterogeneous disorder lacking an established therapeutic strategy. Historical treatment attempts with pepsin products were shrugged off, as a simple calculation shows that quantitative substitution is pointless. However, such attempts might have been right for the wrong reason. Summary: Today, the role of pepsins is primarily seen in the provision of signalling amino acids (especially phenylalanine and tryptophan) and peptides, which initiate processes promoting digestion. Proteolysis benefits from pepsin variants showing, contrary to common belief, activities of up to a pH value of 5.0. Non-clinical and clinical studies support the view that liberated amino acids produce a variety of direct and indirect effects. Signal chains stimulated by (mostly aromatic) amino acids lead to secretion of gastrin and cholecystokinin (CCK), mediated, respectively, by CCK2 (gastrin) and Ca2+-sensing receptors in the parietal cell, and Ca2+-sensing receptors in the antral and duodenal mucosa. Thus, CCK effects such as secretion of pancreatic enzymes and promotion of gastric accommodation are (also) consequential to peptic liberation of amino acids. Key Message: As functional dyspepsia represents a heterogeneous disorder, it may be intriguing to view pepsin as a potential (although still to be proven) treatment modality, distinguished by a diversity of pro-digestive effects.

1.
Goodman L, Gilman A: The Pharmacological Basis of Therapeutics, ed 1. New York, Macmillan, 1941.
2.
Nawrot-Porąbka K, Jaworek J, Leja-Szpak A, Szklarczyk J, Konturek SJ, Reiter RJ: Luminal melatonin stimulates pancreatic enzyme secretion via activation of serotonin-dependent nerves. Pharmacol Rep 2013; 65: 494–504.
3.
Roberts NB: Review article: human pepsins – their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther 2006; 24(suppl 2):2–9.
4.
Taylor WH: Studies on gastric proteolysis. 2. The nature of the enzyme-substrate interaction responsible for gastric proteolytic pH-activity curves with two maxima. Biochem J 1959; 71: 373–383.
5.
Piper DW, Fenton BH: pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 1965; 6: 506–508.
6.
Buchs S: [What’s the reaon for the gastric mucosa to secrete pepsines and hydrochloric acid?] Wozu sezerniert die Magenschleimhaut Pepsine und Salzsäure? Dtsch Med Wochenschr 1974; 99: 332–338.
7.
Huang WY, Tang J: On the specificity of human gastricsin and pepsin. J Biol Chem 1969; 244: 1085–1091.
8.
Buchs S: [On the mechanism of action of pepsines in the stomach] Zum Wirkungsmechanismus der Pepsine im Magen. Das Med Lab 1974; 27: 235–241.
9.
Palashoff MH: Determining the Specificity of Pepsin for Proteolytic Digestion (Thesis), Boston (USA), Northeastern University, 2008. https://repository.library.northeastern.edu/downloads/neu:2209?datastream_id=content.
10.
Conigrave AD, Franks AH, Brown EM, Quinn SJ: L-amino acid sensing by the calcium-sensing receptor: a general mechanism for coupling protein and calcium metabolism? Eur J Clin Nutr 2002; 56: 1072–1080.
11.
Conigrave AD, Mun HC, Brennan SC: Physiological significance of L-amino acid sensing by extracellular Ca(2+)-sensing receptors. Biochem Soc Trans 2007; 35: 1195–1198.
12.
Colella M, Gerbino A, Hofer AM, Curci S: Recent advances in understanding the extracellular calcium-sensing receptor. F1000Res 2016; 5. pii: F1000 Faculty Rev-2535.
13.
Macleod RJ: CaSR function in the intestine: Hormone secretion, electrolyte absorption and secretion, paracrine non-canonical Wnt signaling and colonic crypt cell proliferation. Best Pract Res Clin Endocrinol Metab 2013; 27: 385–402.
14.
Conigrave AD, Quinn SJ, Brown EM: L-amino acid sensing by the extracellular Ca2+-sensing receptor. Proc Natl Acad Sci U S A 2000; 97: 4814–4819.
15.
Busque SM, Kerstetter JE, Geibel JP, Insogna K: L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells. Am J Physiol Gastrointest Liver Physiol 2005; 289:G664–G669.
16.
Ray JM, Squires PE, Curtis SB, Meloche MR, Buchan AM: Expression of the calcium-sensing receptor on human antral gastrin cells in culture. J Clin Invest 1997; 99: 2328–2333.
17.
Cheng I, Qureshi I, Chattopadhyay N, Qureshi A, Butters RR, Hall AE, Cima RR, Rogers KV, Hebert SC, Geibel JP, Brown EM, Soybel DI: Expression of an extracellular calcium-sensing receptor in rat stomach. Gastroenterology 1999; 116: 118–126.
18.
Geibel JP, Wagner CA, Caroppo R, Qureshi I, Gloeckner J, Manuelidis L, Kirchhoff P, Radebold K: The stomach divalent ion-sensing receptor SCAR is a modulator of gastric acid secretion. J Biol Chem 2001; 276: 39549–39552.
19.
Chattopadhyay N, Cheng I, Rogers K, Riccardi D, Hall A, Diaz R, Hebert SC, Soybel DI, Brown EM: Identification and localization of extracellular Ca(2+)-sensing receptor in rat intestine. Am J Physiol 1998; 274:G122–G130.
20.
Liou AP, Sei Y, Zhao X, Feng J, Lu X, Thomas C, Pechhold S, Raybould HE, Wank SA: The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol 2011; 300:G538–G546.
21.
Wang Y, Chandra R, Samsa LA, Gooch B, Fee BE, Cook JM, Vigna SR, Grant AO, Liddle RA: Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor. Am J Physiol Gastrointest Liver Physiol 2011; 300;G528–G537.
22.
Meyer JH, Kelly GA: Canine pancreatic responses to intestinally perfused proteins and protein digests. Am J Physiol 1976; 231: 682–691.
23.
Guan D, Green GM: Significance of peptic digestion in rat pancreatic secretory response to dietary protein. Am J Physiol 1996; 271:G42–G47.
24.
Konturek SJ, Radecki T, Thor P, Dembinski A: Release of cholecystokinin by amino acids. Proc Soc Exp Biol Med 1973; 143: 305–309.
25.
Himeno S, Tarui S, Kanayama S, Kuroshima T, Shinomura Y, Hayashi C, Tateishi K, Imagawa K, Hashimura E, Hamaoka T: Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay. Am J Gastroenterol 1983; 78: 703–707.
26.
Mearadji B, Masclee AA, Onkenhout W, Biemond I, Lamers CB: Effect of intraduodenal and intravenous amino acids on proximal gastric motor function in man. Dig Dis Sci 2001; 46: 38–45.
27.
Steinert RE, Landrock MF, Horowitz M, Feinle-Bisset C: Effects of intraduodenal infusions of l-phenylalanine and l-glutamine on antropyloroduodenal motility and plasma cholecystokinin in healthy men. J Neurogastroenterol Motil 2015; 21: 404–413.
28.
Chang CH , Chey WY, Sun Q, Leiter A, Chang TM: Characterization of the release of cholecystokinin from a murine neuroendocrine tumor cell line, STC-1. Biochim Biophys Acta 1994; 1221: 339–3347.
29.
Hira T, Nakajima S, Eto Y, Hara H: Calcium-sensing receptor mediates phenylalanine-induced cholecystokinin secretion in enteroendocrine STC-1 cells. FEBS J 2008; 275: 4620–4626.
30.
Nakajima S, Hira T, Hara H: Calcium-sensing receptor mediates dietary peptide-induced CCK secretion in enteroendocrine STC-1 cells. Mol Nutr Food Res 2012; 56: 753–760.
31.
Daly K, Al-Rammahi M, Moran A, Marcello M, Ninomiya Y, Shirazi-Beechey SP: Sensing of amino acids by the gut-expressed taste receptor T1R1-T1R3 stimulates CCK secretion. Am J Physiol Gastrointest Liver Physiol 2013; 304:G271–G282.
32.
Koop I, Buchan AM: Cholecystokinin release from isolated canine epithelial cells in short-term culture. Gastroenterology 1992; 102: 28–34.
33.
Richardson CT, Walsh JH, Hicks MI, Fordtran JS: Studies on the mechanisms of food-stimulated gastric acid secretion in normal human subjects. J Clin Invest 1976; 58: 623–631.
34.
Cieszkowski M, Konturek SJ, Obtulowicz W, Tasler J: Chemical stimulatory mechanism in gastric secretion. J Physiol 1975; 246: 143–157.
35.
Debas HT, Grossman MI: Chemicals bathing the oxyntic gland area stimulate acid secretion in dog. Gastroenterology 1975; 69: 654–659.
36.
Konturek SJ, Tasler J, Cieszkowski M, Dobrzańska M, Wünsch E: Stimulation of gastrin release and gastric secretion by amino acids bathing pyloric gland area. Am J Physiol 1977; 233:E170–E174.
37.
McArthur KE, Isenberg JI, Hogan DL, Dreier SJ: Intravenous infusion of L-isomers of phenylalanine and tryptophan stimulate gastric acid secretion at physiologic plasma concentrations in normal subjects and after parietal cell vagotomy. J Clin Invest 1983; 71: 1254–1262.
38.
Taylor IL, Byrne WJ, Christie DL, Ament ME, Walsh JH: Effect of individual l-amino acids on gastric acid secretion and serum gastrin and pancreatic polypeptide release in humans. Gastroenterology 1982; 83: 273–278.
39.
Konturek SJ, Tasler J, Obtulowicz W, Cieszkowski M: Comparison of amino acids bathing the oxyntic gland area in the stimulation of gastric secretion. Gastroenterology 1976; 70: 66–69.
40.
Konturek SJ, Tasler J, Cieszkowski M, Jaworek J: Comparison of intravenous amino acids in the stimulation of gastric secretion. Gastroenterology 1978; 75: 817–824.
41.
Walsh JH, Richardson CT, Fordtran JS: pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462–468.
42.
DelValle J, Yamada T: Amino acids and amines stimulate gastrin release from canine antral G-cells via different pathways. J Clin Invest 1990; 85: 139–143.
43.
Strunz UT, Walsh JH, Grossman MI: Stimulation of gastrin release in dogs by individual amino acids. Proc Soc Exp Biol Med 1978; 157: 440–441.
44.
Feng J, Petersen CD, Coy DH, Jiang JK, Thomas CJ, Pollak MR, Wank SA: Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion. Proc Natl Acad Sci U S A 2010; 107: 17791–17796.
45.
Burn-Murdoch RA, Fisher MA, Hunt JN: The slowing of gastric emptying by proteins in test meals. J Physiol 1978; 274: 477–485.
46.
Cooke AR, Moulang J: Control of gastric emptying by amino acids. Gastroenterology 1972; 62: 528–532.
47.
Mangel AW, Koegel A: Effects of peptides on gastric emptying. Am J Physiol 1984; 246: G342–G345.
48.
Stephens JR, Woolson RF, Cooke AR: Effects of essential and nonessential amino acids on gastric emptying in the dog. Gastroenterology 1975; 69: 920–927.
49.
Debas HT, Farooq O, Grossman MI: Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 1975; 68: 1211–1217.
50.
Steinert RE, Luscombe-Marsh ND, Little TJ, Standfield S, Otto B, Horowitz M, Feinle-Bisset C: Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men. J Clin Endocrinol Metab 2014; 99: 3275–3284.
51.
Straathof JW, Mearadji B, Lamers CB, Masclee AA: Effect of CCK on proximal gastric motor function in humans. Am J Physiol 1998; 274:G939–G944.
52.
Uchida M, Kobayashi O, Iwamoto C: Effects of L-tryptophan on gastric emptying evaluated by breath test in relation to gastric accommodation evaluated by Barostat in rats. J Pharmacol Sci 2015; 127: 229–231.
53.
Stephens JR, Woolson RF, Cooke AR: Effects of essential and nonessential amino acids on gastric emptying in the dog. Gastroenterology 1975; 69: 920–927.
54.
Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N: Ghrelin, CCK, GLP-1, and PYY(3–36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev 2017; 97: 411–463.
55.
Hunt JN, Ramsbottom N: Effect of gastrin II on gastric emptying and secretion during a test meal. Br Med J 1967; 4: 386–387.
56.
Verkijk M, Gielkens HA, Lamers CB, Masclee AA: Effect of gastrin on antroduodenal motility: role of intraluminal acidity. Am J Physiol 1998; 275:G1209–G1216.
57.
Mearadji B , Straathof JW, Lamers CB, Masclee AA: Effect of gastrin on proximal gastric motor function in humans. Neurogastroenterol Motil 1999; 11: 449–455.
58.
Lu YX, Owyang C: Duodenal acid-induced gastric relaxation is mediated by multiple pathways. Am J Physiol 1999; 276:G1501–G1506.
59.
Conigrave AD, Brown EM: Taste receptors in the gastrointestinal tract. II. L-amino acid sensing by calcium-sensing receptors: implications for GI physiology. Am J Physiol Gastrointest Liver Physiol 2006; 291:G753–G761.
60.
Moran TH, Kinzig KP: Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004; 286:G183–G188.
61.
Kindt S, Tack J: Impaired gastric accommodation and its role in dyspepsia. Gut 2006; 55: 1685–1691.
62.
Dufresne M, Seva C, Fourmy D: Cholecystokinin and gastrin receptors. Physiol Rev 2006; 86: 805–847.
63.
Azpiroz F, Feinle-Bisset C, Grundy D, Tack J: Gastric sensitivity and reflexes: basic mechanisms underlying clinical problems. J Gastroenterol 2014; 49: 206–218.
64.
Tack J, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239–1255.
65.
Karamanolis G, Caenepeel P, Arts J, Tack J: Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006; 130: 296–303.
66.
Haag S, Senf W, Tagay S, Heuft G, Gerken G, Talley NJ, Holtmann G: Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil 2010; 22: 262.e79.
67.
Tack J, Coulie B, Verbeke K, Janssens J: Influence of delaying gastric emptying on meal-related symptoms in healthy subjects. Aliment Pharmacol Ther 2006; 24: 1045–1050.
68.
Tack J, Janssen P, Masaoka T, Farré R, Van Oudenhove L: Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2012; 10: 1239–1245.
69.
Tack J: Dyspesia; in Feldman F, Friedman LS, Brandt LJ, Qayed E (eds): Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Review and Assessment, ed 10. Philadelphia (USA), Elsevier-Saunders, 2016, pp 194–206.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.